MAPK3 and melanoma: These contrasting effects on the expression of Noxa were associated with differential impacts of PLX4720 on activation of ERK1/2, which was, as anticipated, inhibited in BRAFV600E, but enhanced in BRAFWT, melanoma cells (Figures 2A and B) [32-34].